NCT01534520View on ClinicalTrials.gov

Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Pain
Interventions
DRUG

Lidocaine

Intravaginal insertion of 4mL 2% lidocaine gel

DRUG

Placebo

KY Jelly

Trial Locations (1)

15213

Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

University of Pittsburgh

OTHER

NCT01534520 - Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women | Biotech Hunter | Biotech Hunter